Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Equities

688336

CNE1000062X2

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-07-21 pm EDT 5-day change 1st Jan Change
19.66 CNY +1.44% Intraday chart for Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd +2.13% -12.66%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Chart Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
More charts
Sunshine Guojian Pharmaceutical Shanghai Co Ltd is a China-based company mainly engaged in the research and development, industrialization and commercialization of antibody drugs. Its products are mainly used to treat major diseases such as autoimmune diseases and tumors. The Company’s product, recombinant human type II tumor necrosis factor receptor-antibody fusion protein (trade name: YISAIPU), is a fully human antibody drug used to treat rheumatoid arthritis, ankylosing spondylitis and psoriasis. The Company mainly conducts its businesses in Mainland China.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
19.66 CNY
Average target price
32.43 CNY
Spread / Average Target
+64.95%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688336 Stock
  4. News Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
  5. Sunshine Guojian Pharmaceutical Gets Nod to Trial Anti-IL-17A Antibody Injection for Arthritis